Midazolam nasal spray dose
Reading Document
Medical Text Search
midazolam intranasal nasal spray dose pediatric adult
Medical Text Search
intranasal midazolam acute seizure epilepsy dosing
GradeResponse
GradeResponse
Midazolam Intranasal (Nasal Spray) Dosing
Acute Seizures / Status Epilepticus
| Population | Dose | Route | Notes |
|---|---|---|---|
| Children (2 months–15 years) | 0.2 mg/kg | Intranasal | Divide between nostrils; max volume ~0.5 mL per nostril |
| Adults | 5–10 mg (or 0.1–0.2 mg/kg) | Intranasal | Typically 5 mg if <50 kg; 10 mg if ≥50 kg |
Nayzilam (FDA-approved branded intranasal midazolam for acute seizures):
- ≥12 years: 5 mg in one nostril; may repeat 5 mg in the other nostril after 10 minutes if seizure persists
- Maximum: 10 mg per episode
Procedural Sedation / Anxiolysis (pre-procedure)
| Population | Dose | Notes |
|---|---|---|
| Children | 0.2–0.3 mg/kg (max 10 mg) | Onset ~10 min; peak effect at 10–15 min |
| Adults | 2.5–5 mg | Use lower end in elderly or compromised patients |
Key Administration Points
- Concentration: Use the 5 mg/mL parenteral solution via a mucosal atomization device (MAD) for unlicensed use, or the commercial nasal spray (Nayzilam 5 mg/0.1 mL).
- Split the dose: If volume >0.5 mL total, divide between both nostrils to improve absorption.
- Onset: ~5–10 minutes intranasally (slower than IV, faster than oral).
- Repeat dosing: One repeat dose may be given after 10 minutes if response is inadequate (seizure indication).
Contraindications / Cautions
- Acute narrow-angle glaucoma
- Respiratory depression / compromised airway
- Hypersensitivity to benzodiazepines
- Use with caution in elderly, hepatic impairment, or concurrent CNS depressants (additive sedation/respiratory depression risk)
Sources: Treatment of Convulsive Status Epilepticus in Children and Adults (p. 7); Nayzilam prescribing information; supplemented from clinical pharmacology knowledge.
This is a shared conversation. Sign in to Orris to start your own chat.